Chikungunya Virus Glycoproteins in Insect Cells
Author Information
Author(s): Stefan W Metz, Corinne Geertsema, Martina Byron E, Paulina Andrade, Jacco G Heldens, Monique M van Oers, Rob W Goldbach, Just M Vlak, Gorben P Pijlman
Primary Institution: Wageningen University
Hypothesis
Can Chikungunya virus glycoproteins E1 and E2 be effectively expressed and processed in insect cells for vaccine development?
Conclusion
Chikungunya virus glycoproteins can be expressed in insect cells, are properly glycosylated and cleaved, and the E2 subunit can induce neutralizing antibodies in rabbits.
Supporting Evidence
- The glycoproteins were expressed at high levels in insect cells.
- A substantial fraction of the proteins was glycosylated.
- The E2 subunit induced neutralizing antibodies in rabbits.
- The study demonstrated the potential for using E2 in a subunit vaccine.
Takeaway
Scientists found a way to make parts of the Chikungunya virus in insect cells, which could help create a vaccine to protect against the virus.
Methodology
The study used a baculovirus-insect cell expression system to produce and analyze the glycoproteins E1 and E2.
Limitations
The study did not assess the long-term immunogenicity or efficacy of the vaccine candidates in animal models.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website